Pfizer today said it won't apply for an emergency use authorization for its COVID-19 vaccine until late November, all but guaranteeing that the FDA won't be asked to consider approval until after the election. Dan is joined by Moncef Slaoui, the White House's chief scientific advisor to Operation Warp Speed, the public-private partnership created to get a coronavirus vaccine deployed and developed.